These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine. Kaya A, Ceylan AF, Kavutcu M, Santamaria A, Šoltésová Prnová M, Stefek M, Karasu Ç. Drug Chem Toxicol; 2024 Sep; 47(5):710-720. PubMed ID: 37795621 [Abstract] [Full Text] [Related]
3. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine. Elmazoglu Z, Prnova MS, Stefek M, Ceylan AF, Aschner M, Rangel-López E, Santamaria A, Karasu C. Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301 [Abstract] [Full Text] [Related]
5. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose. Elmazoglu Z, Prnova MS, Santamaria A, Stefek M, Karasu C. Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867 [Abstract] [Full Text] [Related]
8. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ. Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532 [Abstract] [Full Text] [Related]
9. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Yülek F, Or M, Ozoğul C, Isik AC, Ari N, Stefek M, Bauer V, Karasu C. Arch Med Res; 2007 Jul; 38(5):503-11. PubMed ID: 17560455 [Abstract] [Full Text] [Related]
10. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway. Du L, Hao M, Li C, Wu W, Wang W, Ma Z, Yang T, Zhang N, Isaac AT, Zhu X, Sun Y, Lu Q, Yin X. Mol Cell Endocrinol; 2017 Sep 05; 452():44-56. PubMed ID: 28501572 [Abstract] [Full Text] [Related]
15. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE, Cotter MA, Basso M, Hohman TC. Diabetologia; 1997 Mar 05; 40(3):271-81. PubMed ID: 9084964 [Abstract] [Full Text] [Related]
16. Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Li QR, Wang Z, Zhou W, Fan SR, Ma R, Xue L, Yang L, Li YS, Tan HL, Shao QH, Yang HY. Neural Regen Res; 2016 Feb 05; 11(2):345-51. PubMed ID: 27073391 [Abstract] [Full Text] [Related]
17. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF. J Ocul Pharmacol Ther; 2000 Apr 05; 16(2):149-60. PubMed ID: 10803425 [Abstract] [Full Text] [Related]
20. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, Bali M, Stefek M, Stolc S, Gajdosik A, Karasu C. Neurochem Res; 2003 Jun 05; 28(6):815-23. PubMed ID: 12718433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]